The "HORIZON BIOADVANCE" trademark, serial number 85707888 , was filed on 20th of August 2012 with a mark drawing code of 3000 and its transaction date is 85707888. Since 17th of March 2014, the document can be found in the L30 law office in the publication and issue section. The employee responsible is KLINE, MATTHEW C and the date it was published for opposition on 07/23/2013. The status of the trademark was checked last on 09/17/2013.

The corresponded responsible for this trademark is Boris Umansky, located at Ladas & Parry LLP, Suite 1600, 224 South Michigan Avenue.

The state or country where the trademark was organized is IN by Horizon Oncology Research, Inc.. The legal entity type behing it is a Corporation, located at Suite 345, Lafayette, IN zip 47905.

GOODS AND/OR SERVICES
International Class - 035 - Advertising; business management; business administration; office functions.
U.S. Class	102 - Insurance and Financial
Class Status	6 - Active
Status Date	08/28/2012
Primary Code	035
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	06/04/2013
Primary Code	042
International Class - 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	06/04/2013
Primary Code	045
Goods codes
CC0000	Color is not claimed as a feature of the mark.
DM0000	The mark consists of the words "HORIZON bioadvance" with five shaded progressively larger circles or dots starting above the letter "i" in the word "bioadvance" and continuing in an arching fashion, with the largest circle ending above the letter "d".
GS0351	Site management organization services, namely, business assistance services for other clinical research organizations, namely, budgeting and contracting, business study feasibilities, creation and implementation of standard operating procedures; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
GS0421	Medical and scientific research, namely, conducting clinical trials and translational research for others; providing medical and scientific research information and laboratory analysis in the field of pharmaceuticals and clinical trials
GS0451	Regulatory compliance consulting services in the pharmaceutical and biotechnology fields
PM0000	HORIZON BIOLOGICAL ADVANCE

TRADEMARK DESIGN SPECIFICATION:
26.01.21 - Circles that are totally or partially shaded.
26.01.30 - Circles, exactly four circles; Four circles

PROSECUTION HISTORY
Date	Description	Type	Code
09/17/2013	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	E	NOAM
07/24/2013	REVIEW OF CORRESPONDENCE COMPLETE	P	CORV
07/23/2013	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	E	NPUB - NOTICE OF PUBLICATION
07/23/2013	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
07/17/2013	ASSIGNED TO PETITION STAFF	A - Allowance for Publication	APET - ASSIGNED TO PETITION STAFF
07/03/2013	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	E	NONP
06/28/2013	TEAS POST PUBLICATION AMENDMENT RECEIVED	I - Incoming Correspondence	EPPA
06/20/2013	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
06/19/2013	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
06/10/2013	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2013	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2013	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2013	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2013	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2012	NOTIFICATION OF NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRN
12/19/2012	NON-FINAL ACTION E-MAILED	F - First Action	GNRT - NON-FINAL ACTION E-MAILED
12/19/2012	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
12/13/2012	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
08/29/2012	NOTICE OF DESIGN SEARCH CODE AND PSEUDO MARK MAILED	O - Outgoing Correspondence	MDSM
08/28/2012	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
08/23/2012	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.